vigilance – Women who used a progestin called Colprone received a letter from the National Agency for the Safety of Medicines and Health Products informing them that they were at greater risk of developing a brain tumor
“Important health information. » Here is the title of a letter received by several women in recent weeks from the National Agency for the Safety of Medicines and Health Products (ANSM) regarding their treatment. The latter warns them about the use of the progestin medrogestone, known as Colprone, which can promote the development of a meningioma. What does this treatment consist of? What are its risks? What to do if you take it? We answer these questions.
What is Colprone?
This medication containing a hormone close to progesterone is used in the treatment of various gynecological disorders, in particular those linked to progesterone insufficiency: cycle irregularity, premenstrual syndrome, breast tension, painful periods, bleeding (especially those due to fibroid), endometriosis or even menopause.
What are its risks?
The ANSM explains that it is an “effective drug but which can promote the development of a meningioma”, a tumor developed from the membrane which surrounds the brain. “Most often these tumors are non-cancerous, however(…) Read more on 20minutes
Also read:
Progestins: Women sue the State after being victims of Androcur
All hormonal contraception leads to increased risk of breast cancer, study finds
Male contraceptive pill: “It would be nice if men could (finally) have one”
Mental health: A study links certain IUDs and depressive disorders
VIDEO. Whistleblower: “The fact that I had five brain tumors was typical of Androcur treatment”
Health
